(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑]-镍(II)配合物催化高对映选择性氰亚胺的环加成反应

doi:10.6023/cjoc202311029

有机化学 ›› 2024, Vol. 44 ›› Issue (7): 2315-2332.DOI: 10.6023/cjoc202311029 上一篇下一篇

研究论文

(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑]-镍(II)配合物催化高对映选择性氰亚胺的环加成反应

曹茜娴, 由君^*(), 刘其业, 刘波, 喻艳超, 武文菊^*()

哈尔滨理工大学材料科学与化学工程学院绿色化工技术黑龙江省高校重点实验室哈尔滨 150080

收稿日期:2023-11-27 修回日期:2024-02-27 发布日期:2024-03-28
基金资助:
国家自然科学基金(22278098); 国家自然科学基金(21908034); 国家自然科学基金(22008045); 黑龙江省自然科学基金(LH2021H001); 黑龙江省自然科学基金(LH2023B013)

(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole]-Ni(II) Complexes Catalyzed Highly Enantioselective Nitrile Imine Cycloaddition Reactions

Xixian Cao, Jun You(), Qiye Liu, Bo Liu, Yanchao Yu, Wenju Wu()

Key Laboratory of Green Chemical Engineering and Technology of College of Heilongjiang Province, College of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin 150080

Received:2023-11-27 Revised:2024-02-27 Published:2024-03-28
Contact: * E-mail: youjunjun@126.com;wuwenju1017@163.com
Supported by:
National Natural Science Foundation of China ((22278098); National Natural Science Foundation of China ((21908034); National Natural Science Foundation of China ((22008045); Natural Science Foundation of Heilongjiang Province(LH2021H001); Natural Science Foundation of Heilongjiang Province(LH2023B013)

文章分享

1. 242315S.pdf(18676KB)

摘要/Abstract

研究了Ni(II)-手性(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑](DBFOX/Ph)金属配合物催化氰亚胺与N-(α,β-不饱和)酰基吡唑的不对称1,3-偶极环加成反应. 该策略为制备包含四取代的一个或两个连续立体中心的手性5-3,5-二甲基吡唑酰基二氢吡唑环加成产物提供了一条简便可行的途径. 研究结果表明, 通过该反应可以高产率(97%)、高区域选择性(100%)和对映选择性(97.5% ee)地得到光学活性的环加成产物. 在放大的克级反应中产物的收率和光学活性均可以很好地保持. 此外, 手性环加成产物可经过亲核和还原等5种反应生成含有不同取代基的手性二氢吡唑衍生物.

关键词: (4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑](DBFOX/Ph), 1,3-偶极环加成, 氰亚胺, N-(α,β-不饱和)酰基吡唑, 对映体选择性, 电子圆二色谱(ECD)计算

The Ni(II)-chiral (4S,4'S)-2,2'-(4,6-dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole] (DBFOX/Ph)-catalyzed asymmetric 1,3-dipolar cycloadditions of nitrile imines to N-α,β-unsaturated acylpyrazoles was presented. This tactic rendered a facile and feasible route to prepare the optically active tetrasubstituted 5-3,5-dimethylpyrazole acyl dihydropyrazole cycloadducts bearing one or two contiguous stereocenters in good yields (up to 97% yield) with high regioselectivities (100%) and enantioselectivities (up to 97.5% ee). Following that, chiral cycloadducts could be obtained consistently in good chemical yields with excellent enantioselectivities within the gram scale process, additionally, toward five kinds of derivatization reactions like nucleophilic and reduction for further conversion of chiral cycloadducts to related chiral dihydropyrazole derivatives encompassing different substituents.

Key words: (4S,4'S)-2,2'-(4,6-dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole] (DBFOX/Ph), 1,3-dipolar cycloaddition, nitrile imines, N-α,β-unsaturated acylpyrazole, enantioselectivity, electronic circular dichroism (ECD) calculation

引用此文

曹茜娴, 由君, 刘其业, 刘波, 喻艳超, 武文菊. (4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑]-镍(II)配合物催化高对映选择性氰亚胺的环加成反应[J]. 有机化学, 2024, 44(7): 2315-2332.

Xixian Cao, Jun You, Qiye Liu, Bo Liu, Yanchao Yu, Wenju Wu. (4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole]-Ni(II) Complexes Catalyzed Highly Enantioselective Nitrile Imine Cycloaddition Reactions[J]. Chinese Journal of Organic Chemistry, 2024, 44(7): 2315-2332.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑]-镍(II)配合物催化高对映选择性氰亚胺的环加成反应”的文章，特向您推荐。请打开下面的网址：https://sioc-journal.cn/Jwk_yjhx/CN/abstract/abstract350688.shtml' name="neirong"> S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑]-镍(II)配合物催化高对映选择性氰亚胺的环加成反应'>

()

图/表 6

参考文献 48

[1]	Poulsen, P. H.; Li, Y.; Lauridsen, V. H.; Jørgensen, D. K. B.; Palazzo, T. A.; Meazza, M.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2018, 57, 10661.
[2]	Wang, K.; Xiao, Y. Chirality 2021, 33, 424.
[3]	Wang, M.; Zhang, Z.; Zhang, W. Acc. Chem. Res. 2022, 55, 2708.
[4]	Hilpert, L. J.; Sieger, S. V.; Haydl, A. M.; Breit, B. Angew. Chem., Int. Ed. 2019, 131, 3416.
[5]	Zengeya, T. T.; Garlick, J. M.; Kulkarni, R. A.; Miley, M.; Roberts, A. M.; Yang, Y.; Crooks, D. R.; Sourbier, C.; Linehan, W. M.; Meier, J. L. J. Am. Chem. Soc. 2016, 138, 15813. pmid: 27960310
[6]	Nunes, R. C.; Ribeiro, C. J. A.; Monteiro, Â.; Rodrigues, C. M. P.; Amaral, J. D.; Santos, M. M. M. Eur. J. Med. Chem. 2017, 139, 168. doi: S0223-5234(17)30579-2 pmid: 28800455
[7]	Ahsan, M. J.; Ali, A.; Ali, A.; Thiriveedhi, A.; Bakht, M. A.; Yusuf, M.; Salahuddin; Afzal, O.; Altamimi, A. S. A. ACS Omega 2022, 7, 38207.
[8]	Fahrni, C. J.; Yang, L.; VanDerveer, D. G. J. Am. Chem. Soc. 2003, 125, 3799.
[9]	Chen, J. R.; Dong, W. R.; Candy, M.; Pan, F. F.; Jörres, M.; Bolm, C. J. Am. Chem. Soc. 2012, 134, 6924.
[10]	Thomson, C. J.; Barber, D. M.; Dixon, D. J. Angew. Chem., Int. Ed. 2019, 131, 2491.
[11]	Yang, C. J.; Zhang, C.; Gu, Q. S.; Fang, J. H.; Su, X. L.; Ye, L.; Sun, Y.; Tian, Y.; Li, Z. L.; Liu, X. Y. Nat. Catal. 2020, 3, 539.
[12]	Hu, F.; Zhang, H.; Chu, Y.; Hui, X. P. Org. Chem. Front. 2022, 9, 2734.
[13]	Matiadis, D. Adv. Synth. Catal. 2023, 365, 1934.
[14]	Yamashita, Y.; Kobayashi, S. J. Am. Chem. Soc. 2004, 126, 11279. pmid: 15355109
[15]	Wang, C.; Wen, D.; Chen, H.; Deng, Y.; Liu, X.; Liu, X.; Wang, L.; Gao, F.; Guo, Y.; Sun, M.; Wang, K.; Yan, W. Org. Biomol. Chem. 2019, 17, 5514. doi: 10.1039/c9ob00720b pmid: 31115424
[16]	Hashimoto, T.; Takiguchi, Y.; Maruoka, K. J. Am. Chem. Soc. 2013, 135, 11473. doi: 10.1021/ja405444c pmid: 23869712
[17]	Zhang, D. Y.; Shao, L.; Xu, J.; Hu, X. P. ACS Catal. 2015, 5, 5026.
[18]	Deepthi, A.; Acharjee, N.; Sruthi, S. L.; Meenakshy, C. B. Tetrahedron 2022, 116, 132812.
[19]	Song, L.; Lai, Y.; Li, H.; Ding, J.; Yao, H.; Su, Q.; Huang, B.; Ouyang, M. A.; Tong, R. J. Org. Chem. 2022, 87, 10550.
[20]	Sibi, M. P.; Stanley, L. M.; Jasperse, C. P. J. Am. Chem. Soc. 2005, 127, 8276.
[21]	Wang, G.; Liu, X.; Huang, T.; Kuang, Y.; Lin, L.; Feng, X. Org. Lett. 2013, 15, 76.
[22]	Gerten, A. L.; Slade, M. C.; Pugh, K. M.; Stanley, L. M. Org. Biomol. Chem. 2013, 11, 7834.
[23]	Pellissier, H. Tetrahedron 2007, 63, 3235.
[24]	Hashimoto, T.; Maruoka, K. Chem. Rev. 2015, 115, 5366. doi: 10.1021/cr5007182 pmid: 25961125
[25]	Nishiura, Y.; Gonzalez, K. J.; Cusumano, A. Q.; Stoltz, B. M. Org. Lett. 2023, 25, 6469.
[26]	Wu, D.; Qiu, J.; Li, C.; Yuan, L.; Yin, H.; Chen, F. X. J. Org. Chem. 2019, 85, 934.
[27]	Wang, C. J.; Sun, J.; Zhou, W.; Xue, J.; Ren, B. T. Zhang, G. Y. Mei, Y. L. Deng, Q. H. Org. Lett. 2019, 21, 7315.
[28]	Shen, X.; Li, Y.; Wen, Z.; Cao, S.; Hou, X.; Gong, L. Chem. Sci. 2018, 9, 4562.
[29]	Itoh, K.; Sibi, M. P. Org. Biomol. Chem. 2018, 16, 5551.
[30]	Kanemasa, S.; Oderaotoshi, Y.; Tanaka, J.; Wada, E. J. Am. Chem. Soc. 1998, 120, 12355.
[31]	Yang, X.; Cheng, F.; Kou, Y. D.; Pang, S.; Shen, Y. C.; Huang, Y. Y.; Shibata, N. Angew. Chem., Int. Ed. 2017, 129, 1532.
[32]	Liu, X.; Li, M.; You, J.; Liu, B. Chin. J. Org. Chem. 2017, 37, 86. (in Chinese)
	(刘迅绅, 李美美, 由君, 刘波, 有机化学, 2017, 37, 86.)
[33]	Ono, F.; Ohta, Y.; Hasegawa, M.; Kanemasa, S. Tetrahedron Lett. 2009, 50, 2111.
[34]	Zhang, J.; Liu, X.; Wang, R. Chem- Eur. J. 2014, 20, 4911.
[35]	Zhang, Y.; Liao, Y.; Liu, X.; Yao, Q.; Zhou, Y.; Lin, L.; Feng, X. Chem.-Eur. J. 2016, 22, 15119. doi: 10.1002/chem.201603056 pmid: 27576747
[36]	Yao, Q.; Wang, Z.; Zhang, Y.; Liu, X.; Lin, L.; Feng, X. J. Org. Chem. 2015, 80, 5704.
[37]	Liu, X. H.; Ruan, B. F.; Li, J.; Chen, F. H.; Song, B. A.; Zhu, H. L.; Bhadury, P. S.; Zhao, J. Mini-Rev. Med. Chem. 2011, 11, 771.
[38]	Küçükgüzel, Ş. G.; Şenkardeş, S. Eur. J. Med. Chem. 2015, 97, 786. doi: 10.1016/j.ejmech.2014.11.059 pmid: 25555743
[39]	Liu, H.; Jia, H.; Wang, B.; Xiao, Y.; Guo, H. Org. Lett. 2017, 19, 4714.
[40]	Wang, Y.; Zhang, P.; Di, X.; Dai, Q.; Zhang, Z. M.; Zhang, J. Angew. Chem., Int. Ed. 2017, 129, 16121.
[41]	Lu, T. Molclus program, Version 1. 5,
[42]	Stewart, J. J. P. J. Comput.-Aided Mol. Des. 1990, 4, 1.
[43]	Hohenberg, P.; Kohn, W. Phys. Rev. 1964, 136, B864.
[44]	Kohn, W.; Sham, L. J. Phys. Rev. 1965, 140, A1133.
[45]	Grimme, S.; Antony. J.; Ehrlich, S.; Krieg, H. J. Chem. Phys. 2010, 132, 154104.
[46]	Petersson, G. A.; Bennett, A.; Tensfeldt, T. G; Al-Laham, M. A.; Shirley, W. A.; Mantzaris, J. J. Chem. Phys. 1988, 89, 2193.
[47]	Weigend, F.; Ahlrichs, R. Phys. Chem. Chem. Phys. 2005, 7, 3297.
[48]	Lu, T.; Chen, F. J. Comput. Chem. 2012, 33, 580.

Entry	Ligand^b	Metal salt	Solvent	Base	Yield^c/%	ee^d/%
1	L1	Ni(ClO₄)₂	DCM	DIPEA	88	5.0
2	L2	Ni(ClO₄)₂	DCM	DIPEA	90	7.0
3	L3	Ni(ClO₄)₂	DCM	DIPEA	91	3.0
4	L4	Ni(ClO₄)₂	DCM	DIPEA	88	13.1
5	L5	Ni(ClO₄)₂	DCM	DIPEA	90	5.1
6	L6	Ni(ClO₄)₂	DCM	DIPEA	93	62.0
7	L7	Ni(ClO₄)₂	DCM	DIPEA	90	6.0
8	L8	Ni(ClO₄)₂	DCM	DIPEA	90	7.1
9	L6	Mg(NTf₂)₂	DCM	DIPEA	92	38.3
10	L6	Cu(CH₃CN)₄•PF₆	DCM	DIPEA	90	42.2
11	L6	Sc(OTf)₃	DCM	DIPEA	87	37.0
12	L6	Zn(OTf)₂	DCM	DIPEA	89	32.1
13	L6	Ni(ClO₄)₂	Et₂O	DIPEA	91	46.2
14	L6	Ni(ClO₄)₂	Toluene	DIPEA	92	39.1
15	L6	Ni(ClO₄)₂	DCE	DIPEA	95	82.0
16	L6	Ni(ClO₄)₂	THF	DIPEA	93	43.3
17	L6	Ni(ClO₄)₂	DCE	NMM	40	46.0
18	L6	Ni(ClO₄)₂	DCE	Pyridine	10	0
19	L6	Ni(ClO₄)₂	DCE	DBU	0	0

Entry	Ligand^b	Metal salt	Solvent	Base	Yield^c/%	ee^d/%
1	L1	Ni(ClO₄)₂	DCM	DIPEA	88	5.0
2	L2	Ni(ClO₄)₂	DCM	DIPEA	90	7.0
3	L3	Ni(ClO₄)₂	DCM	DIPEA	91	3.0
4	L4	Ni(ClO₄)₂	DCM	DIPEA	88	13.1
5	L5	Ni(ClO₄)₂	DCM	DIPEA	90	5.1
6	L6	Ni(ClO₄)₂	DCM	DIPEA	93	62.0
7	L7	Ni(ClO₄)₂	DCM	DIPEA	90	6.0
8	L8	Ni(ClO₄)₂	DCM	DIPEA	90	7.1
9	L6	Mg(NTf₂)₂	DCM	DIPEA	92	38.3
10	L6	Cu(CH₃CN)₄•PF₆	DCM	DIPEA	90	42.2
11	L6	Sc(OTf)₃	DCM	DIPEA	87	37.0
12	L6	Zn(OTf)₂	DCM	DIPEA	89	32.1
13	L6	Ni(ClO₄)₂	Et₂O	DIPEA	91	46.2
14	L6	Ni(ClO₄)₂	Toluene	DIPEA	92	39.1
15	L6	Ni(ClO₄)₂	DCE	DIPEA	95	82.0
16	L6	Ni(ClO₄)₂	THF	DIPEA	93	43.3
17	L6	Ni(ClO₄)₂	DCE	NMM	40	46.0
18	L6	Ni(ClO₄)₂	DCE	Pyridine	10	0
19	L6	Ni(ClO₄)₂	DCE	DBU	0	0

Entry	Temp./℃	Amount^b/mol%	Yield/%	ee/%
1	10	6	94	83.7
2	30	6	95	82.0
3	40	6	90	83.0
4	50	6	91	83.8
5	65	6	82	42.7
6	0	6	95	89.0
7	–10	6	90	82.5
8	–30	6	92	71.1
9	–40	6	80	55.1
10	–50	6	75	40.5
11	–65	6	20	12.0
12	0	8	95	92.0
13	0	10	97	97.5
14	0	12	96	97.6

Entry	Temp./℃	Amount^b/mol%	Yield/%	ee/%
1	10	6	94	83.7
2	30	6	95	82.0
3	40	6	90	83.0
4	50	6	91	83.8
5	65	6	82	42.7
6	0	6	95	89.0
7	–10	6	90	82.5
8	–30	6	92	71.1
9	–40	6	80	55.1
10	–50	6	75	40.5
11	–65	6	20	12.0
12	0	8	95	92.0
13	0	10	97	97.5
14	0	12	96	97.6

(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基噁唑]-镍(II)配合物催化高对映选择性氰亚胺的环加成反应

(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole]-Ni(II) Complexes Catalyzed Highly Enantioselective Nitrile Imine Cycloaddition Reactions

RichHTML

PDF

补充材料

可视化

摘要/Abstract

引用此文

分享此文

图/表 6

参考文献 48

相关文章 5

编辑推荐

相关统计

本文评价

[1]	李明龙, 曹茜娴, 由君, 喻艳超, 武文菊, 刘波. 手性双噁唑啉金属络合物催化N-α,β-不饱和酰基化合物与C,N-二芳基硝酮的不对称1,3-偶极环加成反应[J]. 有机化学, 2019, 39(6): 1642-1649.
[2]	刘迅绅, 李美美, 由君, 刘波. Ni-DBFOX/Ph催化N-α,β-不饱和酰基吡唑与C,N-二芳基硝酮的不对称1,3-偶极环加成反应[J]. 有机化学, 2017, 37(1): 86-91.
[3]	李小娜, 王丽华, 周宏勇, 王家喜. 手性氨基酸衍生物-钌配合物催化的酮不对称氢转移反应[J]. 有机化学, 2016, 36(9): 2175-2182.
[4]	高剑; 黄祎先 ; 伍贻康*. Brefeldin A全合成研究新进展[J]. 有机化学, 2009, 29(02): 206-215.
[5]	杨永青,伍贻康. 抗霉素合成概览[J]. 有机化学, 2006, 26(10): 1370-1377.